Validation of a simple activity participation measure for rheumatoid arthritis clinical trials

Rheumatology

Volumn 48, Issue 2, 2009, Pages 170-175

  Li, Tracy ^a   Wells, G ^b   Westhovens, R ^c   Tugwell, P ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Abatacept; Activity participation; Quality of life; Rheumatoid arthritis

Indexed keywords

ABATACEPT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; PLACEBO;

ACTIVITY PARTICIPATION QUESTIONNAIRE; ADULT; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONSTRUCT VALIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN; PATIENT PARTICIPATION; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RHEUMATOID ARTHRITIS; SELF REPORT; SENSITIVITY AND SPECIFICITY; TEST RETEST RELIABILITY; VALIDATION STUDY;

ACTIVITIES OF DAILY LIVING; ARTHRITIS, RHEUMATOID; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 58749087535     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken448     Document Type: Article

References (35)

1. World Health Organization. International classification of functioning, disability and health: ICF. Geneva: WHO. 2001.
2. Stucki G, Cieza.A, Geyh S et al. ICF core sets for rheumatoid arthritis. J Rehabil Med 2004;36(Suppl. 44):87-93.
3. Stucki G, Boonen A, Tugwell P, Cieza A, Boers M. The World Health Organisation International Classification of Functioning, Disability and Health: A conceptual model and interface for the OMERACT process. J Rheumatol 2007;34:600-6.
4. Reinhardt JD, Stucki G. Rheumatoid arthritis and participation - the social animal revisited. J Rheumatol 2007;34:1214-6.
5. Simpson C, Franks C, Morrison C, Lempp H. The patient's journey: rheumatoid arthritis. Br Med J 2005;331:887-9.
6. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: The health assessment questionnaire, disability and pain scales. J Rheumatol 1982;9:789-93.
7. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 1992;35:1-10.
8. Geuskens GA, Burdorf A, Hazes JM. Consequences of rheumatoid arthritis for performance of social roles - a literature review. J Rheumatol 2007;34:1248-260.
9. Fyrand L, Moum T, Wichstrom L, Finset A, Glennas A. Social network size of female patients with rheumatoid arthritis compared to healthy controls. Scand J Rheumatol 2000;29:38-43.
10. Yelin E, Lubeck D, Holman H, Epstein W. The impact of rheumatoid arthritis and osteoarthritis: The activities of patients with rheumatoid arthritis and osteoarthritis compare to controls. J Rheumatol 1987;14:710-7.
11. Katz PP The impact of rheumatoid arthritis on life activities. Arthritis Care Res 1995;8:272-8.
12. Goodcare L, Smith J, Meddis D, Goodacre J. Development and validation of a patient-centred measure of activity limitation (MAL) in rheumatoid arthritis. Rheumatology 2007;46:703-8.
13. Lemer D, Amick BC 3rd, Rogers WH, Malspeis S, Bungay K, Cynn D. The Work Limitations Questionnaire. Med Care 2001;39:72-85.
14. Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C. Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc 2002;77:179-87.
15. Kremer M, Genant HK, Moreland LW et al. Effects of abatacept in patients with method axate-resistant active rheumatoid arthritis: A randomized trial. Ann Intern Med 2006;114:865-76.
16. Genovese MC, Becker JC, Schiff M et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med 2005;353:1114-23.
17. National Center for Health Statistics. National Health Interview Survey questionnaire. Hyattsville, MD: US Department of Health and Human Services, 2006.
18. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
19. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
20. van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
21. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwan MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
22. Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 2004;43:1252-5.
23. Vrijhoef HJ, Diederiks JP, Spreeuwenberg C, Van der Linden S. Applying low disease activity criteria using the DAS28 to assess stability in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:419-22.
24. van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845-50.
25. van Gestel AM, Anderson JJ, van Riel PL et al. ACH and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol 1999;26:705-11.
26. Wells GA, Boers M, Shea B et al. Minimal disease activity for rheumatoid arthritis: A preliminary definition. J Rheumatol 2005;32:2016-24.
27. Wells G, Boers M, Tugwell P. Low disease activity state in rheumatoid arthritis: Concepts and derivation of minimal disease activity. Clin Exp Rheumatol 2006;24 (6 Suppl. 43):S52-9.
28. Wolfe F. Fatigue assessments in rheumatoid arthritis: Comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheumatol 2004;31:1896-902.
29. Nunnally JC. Psychometric theory, 2nd edition. New York: McGraw Hill, 1978.
30. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28:542-7.
31. Lemer D, Amick BC 3rd, Lee JC et al. Relationship of employee-reported work limitations to work productivity. Med Care 2003;41:649-59.
32. Verstappen SM, Boonen A, Billsma JW et al. Working status among Dutch patients with rheumatoid arthritis: Work disability and working conditions. Rheumatology 2005;44:202-6.
33. Anis A, Zhang W, Emery P et al. Work-related outcomes in early active rheumatoid arthritis: Results from the COMET trial. Ann Rheum Dis 2008;67(Suppl. II):79.
34. Hurny C, Bernhard J, Coates A et al. Responsiveness of a single-item indicator versus a multi-item scale: Assessment of emotional well-being in an international adjuvant breast cancer trial. Med Care 1996;34:234-48.
35. Lofland JH, Pizzi L, Frick KD. A review of health-related workplace productivity loss instruments Pharmacoeconomics 2004;22:165-84.